Can you trust an article’s abstract?
Abstract ‘spin’ can distort a study’s findings and lead to inappropriate conclusions being drawn. But just how prevalent is this problem?
[VIDEO] Professional medical writing support and the quality, ethics and timeliness of clinical trial reporting: a systematic review
Obaro Evuarherhe, Principal Consultant at Oxford PharmaGenesis, discusses professional medical writing support and the quality, ethics and timeliness of clinical trial reporting.
Does professional medical writing support impact the quality, ethics and timeliness of clinical trial reporting?
Findings of a systematic review show working with professional medical writers positively affects measures of quality, ethics and timeliness.
AMWA–EMWA–ISMPP joint position statement on predatory publishing
In an article in Current Medical Research & Opinion, three leading medical publishing organisations provide guidance on dealing with predatory publishers.
GPCAP recommendations fill an important gap
Specific guidelines describing best practice for developing conference abstracts and presentations are now available.
Disparities claimed between stance and action on clinical trial outcome reporting by top medical journals
Selective reporting of clinical trial outcomes may be widespread. This study reports instances occurring in CONSORT-endorsing medical journals.
Increasing quality and transparency of preclinical data: an opportunity for publication professionals?
An article in the MAP newsletter examines how publication professionals could help to increase preclinical publishing standards.
How to overcome the issue of poorly reported clinical trial outcomes
A number of initiatives developed to prevent researchers from only reporting the most impressive outcomes of clinical trials are explored in an opinion piece from The BMJ.
New EU trials tracker reveals that half of European clinical trials have broken reporting rules
Is your institute breaking European clinical trial reporting rules? Find out using the new EU trials tracker, part of the AllTrials initiative.
Are better guidelines needed for ‘encore’ presentations?
Gain a better understanding of issues surrounding the preparation of encore presentations for congresses.
In memory of Professor Doug Altman
The Publication Plan remembers Professor Doug Altman, founder of the EQUATOR network, who passed away last month.
The influence of gender in the academic publishing process
Get up to date on how gender influences the academic publishing process and what can be done to establish gender equity.
New ICMJE data sharing requirements come into effect imminently
Don’t forget! From 1 July 2018, ICMJE requires all reports of clinical trial data to include a data sharing statement.
Inferential statistics and false conclusions: is the p value to blame?
Significance testing and p values are widely used in medical publications, but just how meaningful are they?
Meeting report: summary of the 14th Annual Meeting of ISMPP – Part 2
Missed the 14th Annual Meeting of ISMPP? Read the second part of our meeting report to get up to speed!
Do preprints have a place in today’s reference lists?
Can preprints be cited in the same way as papers published in a peer reviewed journal, or do we need to define new standards?